- €95.92bn
- €95.87bn
- €23.65bn
- 95
- 13
- 85
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 25,098 | 16,631 | 15,133 | 19,523 | 23,651 |
Cost of Revenue | |||||
Gross Profit | 11,541 | 7,645 | 7,307 | 9,385 | 11,059 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21,266 | 15,704 | 14,269 | 17,480 | 20,853 |
Operating Profit | 3,832 | 927 | 864 | 2,043 | 2,798 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,474 | 570 | 268 | -3,120 | 4,756 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,512 | 386 | 68 | -2,426 | 3,520 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2,447 | 352 | 43 | -2,459 | 3,444 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,447 | 352 | 43 | -2,459 | 3,444 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.55 | 1.63 | 0.584 | -4.68 | 9.24 |
Dividends per Share |